Background. Steroid withdrawal (SW) after kidney transplantation is desirab
le to avoid associated serious sine effects. We studied the long-term outco
me of a group of kidney transplant recipients who underwent went SW.
Methods. Between 1991 and 1993, kidney transplant recipients (N = 12) who h
ad posttransplantation diabetes were entered in a prospective trial of SW.
These patients were compared with a demographically similar comparison coho
rt (N = 66). End points of the study were patient and graft survival, incid
ence of late acute and chronic rejection, and changes in diabetes managemen
t.
Results, Previously published data from the SW group at 15 months of follow
-up indicated improvement in diabetes control without any adverse effect on
patient or graft actuarial survival. At long-term follow-up (mean, 56 mont
hs) the improvement in diabetes management was not detectable. The incidenc
e of late acute rejection in SW and cohort groups was 42% and 8%, respectiv
ely (P = .006). Likewise, the incidence of chronic rejection in the SW vers
us cohort group was 42% and 12%, respectively (P = .014).
Conclusions. Although SW appeared to be successful initially, our long-term
data indicate that SW significantly increases the risk of late acute rejec
tion and chronic rejection episodes without benefits in posttransplantation
diabetes management. Steroid withdrawal in patients with posttransplantati
on diabetes should be approached with caution.